NABLA BIO
Nabla is an autoreverse platform that enables the rapid discovery of previously unattainable protein variants with supernatural qualities. Nabla Bio makes new medicines and improve nutrition by engineering novel proteins.
NABLA BIO
Social Links:
Industry:
Biopharma Biotechnology Machine Learning
Founded:
2020-05-29
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.nabla.bio
Total Employee:
1+
Status:
Active
Email Addresses:
http://[email protected]
Total Funding:
11.26 M USD
Technology used in webpage:
Google Apps For Business Squarespace Hosted
Similar Organizations
Engine Biosciences
Engine Biosciences is a biotech company that applies machine learning to genomics for drug discovery.
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Metagenomi
Metagenomi is using the power of metagenomics and machine learning to discover novel genome editing systems.
Current Employees Featured
Founder
Investors List
Zetta Venture Partners
Zetta Venture Partners investment in Seed Round - Nabla Bio
Cantos
Cantos investment in Seed Round - Nabla Bio
Fifty Years
Fifty Years investment in Seed Round - Nabla Bio
Khosla Ventures
Khosla Ventures investment in Seed Round - Nabla Bio
Y Combinator
Y Combinator investment in Pre Seed Round - Nabla Bio
Fifty Years
Fifty Years investment in Pre Seed Round - Nabla Bio
National Science Foundation
National Science Foundation investment in Grant - Nabla Bio
Official Site Inspections
http://www.nabla.bio Semrush global rank: 4.86 M Semrush visits lastest month: 1.82 K
- Host name: 76.76.21.21
- IP address: 76.76.21.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Nabla Bio"
Nabla
Our founders developed the first protein language models in George Church's Lab and founded the company to combine generative models with massively multiplex experiments to design …See details»
Nabla
Founded by pioneers of protein language modeling, Nabla develops generative models, multiplexed screens, and protein characterization technologies and applies them to design …See details»
Nabla Bio - Crunchbase Company Profile & Funding
Nabla Bio is an autoverse platform of proprietary biologically informed machine learning that co-develops antibody drugs.See details»
Nabla Bio - Y Combinator
May 14, 2024 We use AI to design antibodies for intractable diseases. Founded in 2020 by Frances Anastassacos and Surge Biswas, Nabla Bio has 8 employees based in Boston, MA, USA. Nabla Bio is hiring for 1 roles in engineering.See details»
Nabla Bio 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Nabla Bio. Use the PitchBook Platform to explore the full profile.See details»
Nabla Bio - Funding, Financials, Valuation & Investors
Nabla Bio is an autoverse platform of proprietary biologically informed machine learning that co-develops antibody drugs.See details»
Frances Anastassacos, Co-Founder and President of …
Nabla Bio is expanding the universe of druggable targets with AI-powered protein design. Lab-to-Launch LoungeThursday, March 27, 2025Frances Anastassacos, PhD, is President and Co-Founder of Nabla Bio, Inc., a Series A stage biotech …See details»
Nabla Bio - Radical Ventures
Founded by pioneers of protein language modeling, Nabla develops generative models, multiplexed screens, and protein characterization technologies and applies them to design antibodies against the most challenging disease …See details»
Nabla Bio - VentureRadar
"Nabla Bio is an antibody design company. The company’s AI-first protein design platform enables rapid engineering of best-in-class antibody therapeutics. The foundational technology …See details»
NABLA BIO, INC. - National Science Foundation
Dive into the research topics where NABLA BIO, INC. is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.See details»
Nabla Bio - Leadership Team | The Org
The leadership team at Nabla Bio has a history of experience and education in various scientific fields. The team members have worked as scientists at various companies, including George …See details»
Nabla Bio - workinbiotech.com
Nabla Bio is a young biotech startup based in Cambridge, MA that is leveraging the power of artificial intelligence (AI) and machine learning (ML) to co-develop antibodies for difficult-to …See details»
Nabla Bio Advances Generative Protein Design with $26M
May 15, 2024 Nabla Bio, a biotechnology firm specializing in generative protein design, has successfully closed a $26 million Series A financing round, led by Radical Ventures. The …See details»
Nabla Bio pursues genAI protein design with $26M in funding, …
May 15, 2024 Nabla Bio has high hopes of doubling the number of disease-relevant targets that are available to the pharmaceutical industry and has already signed up three drugmakers to …See details»
Designing Antibodies. Why we invested in Nabla Bio - Medium
Dec 6, 2021 Nabla Bio is fixing this. Spun out of Co-Founder & CEO Surge Biswas ’ PhD research at Harvard, Nabla is building Autoverse, a protein design platform that enables …See details»
Nabla Bio Revolutionizes AI-Driven Protein Design with $26M
Nov 25, 2024 Nabla Bio combines AI and wet-lab technologies to design antibodies against challenging targets such as G protein-coupled receptors (GPCRs), ion channels, and …See details»
Nabla Bio: Revolutionizing Antibody Design Through Target …
Jan 9, 2025 In a world saturated with antibody design startups, Nabla Bio emerges with a groundbreaking approach that focuses on engineering drug targets rather than the antibodies …See details»
Nabla Bio raises $11M for an “end-to-end” antibody design platform
Dec 7, 2021 Nabla Bio, a Boston, Massachusetts based startup, announced a $11 million seed round on Monday. The company, founded in May 2020, is looking to enter the increasingly …See details»
Nabla Bio Secures $26M Series A Financing and Collaborations …
We are thrilled to lead Nabla’s Series A.” Nabla Bio launched in December 2021 with funding from Khosla Ventures and Zetta Venture Partners, to apply cutting-edge generative models to the …See details»
With all eyes on AI-protein design, Nabla says it can model …
Nov 22, 2024 The year has also seen a slew of startups launch with aspirations to leverage computational technologies for drug design — and now Nabla Bio claims to have …See details»